| Literature DB >> 29713466 |
Xi Li1, Ying Fu2, Mengyuan Shen1, Danyan Huang3, Xiaoxing Du3, Qingfeng Hu1, Yonglie Zhou1, Dairong Wang4, Yunsong Yu3.
Abstract
Background: The emergence and spread of New Delhi metallo-β-lactamase-producing Enterobacteriaceae has been a serious challenge to manage in the clinic due to its rapid dissemination of multi-drug resistance worldwide. As one main type of carbapenemases, New Delhi metallo-β-lactamase (NDM)is able to confer resistance to almost all β-lactams, including carbapenems, in Enterobacteriaceae. Recently, New Delhi metallo-β-lactamase-5 attracted extensive attention because of increased resistance to carbapenems and widespread dissemination. However, the dissemination mechanism of blaNDM-5 gene remains unclear.Entities:
Keywords: Carbapenem resistance; Enterobacteriaceae; IncX3 type plasmid; blaNDM-5
Mesh:
Substances:
Year: 2018 PMID: 29713466 PMCID: PMC5918551 DOI: 10.1186/s13756-018-0349-6
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 4.887
Clinical characteristics
| Isolates | Date of hospitalization | Date of isolation | Patient Sex | Patient Age (years) | Clinical Sample | Hospital Ward | Clinical Diagnosis | Antimicrobial Therapy | Outcome |
|---|---|---|---|---|---|---|---|---|---|
| EC135 | 2016/5/27 | 2016/6/20 | Male | 85 | Sputum | ICU | Acute renal failure | CPS, LEV | Death |
| KP387 | 2017/6/7 | 2017/6/26 | Male | 40 | blood | Hematology | Myelodysplastic syndromes | TGC, LEV, AMK | Alive |
| EC126 | 2016/7/29 | 2016/8/10 | Female | 76 | urine | Surgery | Uracratia | CPS, TGC | Alive |
| EC734 | 2016/7/27 | 2016/9/9 | Female | 61 | pus | ICU | Kidney neoplasms | CPS, IMP, LEV, TGC | Death |
| EC463 | 2016/10/7 | 2016/10/24 | Male | 16 | blood | Hematology | Acute lymphoblastic leukemia | AMK, IMP, TZP | Alive |
| EC144 | 2016/10/24 | 2016/11/3 | Female | 50 | ascites | Surgery | Gastric cancer | CPS, AMK | Alive |
| EC122 | 2017/5/5 | 2017/5/23 | Male | 69 | urine | ICU | Aspiration pneumonia | TZP, CPS, LEV | Alive |
| EC611 | 2017/6/12 | 2017/7/5 | Male | 72 | ascites | Surgery | Colonic neoplasms | TZP, CPS, IMP | Alive |
| EC418 | 2017/7/11 | 2017/7/22 | Female | 27 | feces | Hematology | Acute myelogenous leukemia | IMP, MEM, LEV | Alive |
| CF418 | 2017/7/11 | 2017/7/22 | Female | 27 | feces | Hematology | Acute myelogenous leukemia | IMP, MEM, LEV | Alive |
| EC310 | 2017/6/20 | 2017/7/29 | Female | 55 | blood | Infectious Disease | Biliary tract infection | CPS, IMP, LEV, ATM, AMK, TGC | Alive |
MNO minocycline, MEM meropenem, LEV levofloxacin, TZP piperacillin/tazobactam, CPS cefperazone/sulbactam, TGC tigecycline, IMP imipenem, AMK amikacin
Fig. 1The dendrogram is based on the similarity of PFGE patterns from 9 blaNDM-5 positive clinical E. coli isolates. The right illustrates results from MLST, hospitals and β-lactamase gene(s)
Fig. 2S1-digested plasmid DNA and southern blot hybridization of blaNDM-5 positive isolates. Bands in A with arrows pointing to them showed positive signals in Southern blot hybridization with the NDM-5 probe. M = Salmonella serotype Braenderup strain H9812 molecular marker. 1 = K. pneumoniae KP387; 2 = E. coli EC135; 3 = E. coli EC463; 4 = E. coli EC734; 5 = E. coli EC144; 6 = E. coli EC122; 7 = E. coli EC418; 8 = C. freundii CF418; 9 = E. coli EC310; 10 = E. coli EC611; 11 = E. coli EC126
Antibiotic susceptibility of NMD5-producing isolates and their transconjugants
| Isolates | MICs (mg/L) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FEP | IPM | NIT | CAZ | AMK | CIP | ATM | TGC | CPS2/1 | MNO | COL | |
| EC126 | > 128 | 8 | 128 | > 128 | > 128 | 128 | > 128 | 0.5 | > 256 | 8 | 0.5 |
| EC135 | 64 | 16 | 64 | > 128 | 128 | 128 | 0.125 | 2 | > 256 | 32 | 0.5 |
| KP387 | 64 | 16 | 128 | > 128 | 1 | 2 | 0.25 | 4 | > 256 | 32 | 0.5 |
| JH387 | 64 | 16 | 16 | > 128 | 0.5 | 0.5 | 0.25 | 0.5 | > 256 | 4 | 0.5 |
| EC463 | > 128 | 64 | 8 | > 128 | 1 | 64 | 32 | 2 | > 256 | 64 | 0.5 |
| JH 463 | 128 | 64 | 16 | > 128 | 1 | 0.125 | 0.125 | 0.25 | > 256 | 2 | < 0.25 |
| EC734 | 64 | 8 | 8 | > 128 | 1 | 64 | 4 | 0.25 | > 256 | 32 | 0.5 |
| JH734 | 64 | 16 | 16 | > 128 | 0.5 | 0.25 | 0.125 | 0.5 | > 256 | 2 | < 0.25 |
| EC611 | 32 | 8 | 8 | > 128 | 1 | 0.0625 | 0.0625 | 0.25 | > 256 | 2 | 0.25 |
| JH611 | 64 | 8 | 8 | > 128 | 0.5 | 0.0625 | 0.125 | 0.5 | > 256 | 2 | 0.25 |
| EC144 | 128 | 32 | 32 | > 128 | > 128 | 64 | 128 | 0.25 | > 256 | 32 | 0.5 |
| JH144 | 128 | 16 | 32 | > 128 | 0.5 | 0.5 | 0.125 | 0.5 | > 256 | 2 | < 0.25 |
| EC122 | > 128 | 32 | 64 | > 128 | > 128 | 64 | > 256 | 8 | > 256 | 128 | 0.5 |
| JH122 | 128 | 16 | 16 | > 128 | 0.5 | 0.5 | 0.125 | 0.5 | > 256 | 2 | < 0.25 |
| EC418 | 32 | 8 | 32 | > 128 | 1 | 0.25 | 0.125 | 1 | > 256 | 48 | 0.5 |
| JH418 | 32 | 8 | 16 | > 128 | 0.5 | 0.25 | 0.125 | 0.5 | > 256 | 2 | < 0.25 |
| CF418 | 32 | 32 | 8 | > 128 | 1 | 0.25 | 0.l25 | 0.5 | > 256 | 4 | 0.5 |
| JHF418 | 16 | 8 | 8 | > 128 | 1 | 0.25 | 0.125 | 0.5 | > 256 | 2 | < 0.25 |
| EC310 | > 128 | 128 | 8 | > 128 | 1 | 8 | 0.19 | 0.5 | > 256 | 2 | 0.5 |
| JHE310 | > 128 | 64 | 8 | > 128 | 0.5 | 0.5 | 0.125 | 0.5 | > 256 | 1 | < 0.25 |
| EC600 | 0.125 | 0.5 | 8 | 0.25 | 0.5 | 0.125 | 0.25 | 0.125 | 0.5 | 1 | < 0.25 |
| ATCC25922a | 0.125 | 0.5 | < 8 | 0.125 | 0.5 | 0.125 | 0.125 | 0.125 | 0.25 | 0.25 | < 0.25 |
FEP cefepime, IMP imipenem, NIT nitrofurantoin, CAZ ceftazidime, AMK amikacin, CIP ciprofloxacin, ATM aztreonam, TGC tigecycline, MNO minocycline, CPS cefperazone/sulbactam, COL colistin
All susceptibility tests were repeated at least three times according to CLSI method. The results of colistin susceptibility were interpreted according to EUCAST breakpoints
aquality control strain
Fig. 3Plasmid analysis of pEC463-NDM5. Schematic map of plasmid p pEC463-NDM5 (a), comparative analysis of three blaNDM-5-carrying IncX3 plasmids (b). The putative open reading frames are shown as arrowheads orrods (less than 130 amino acids). The gene name is shown near the corresponding arrowhead or rod. The depthof shading is indicative of the percentage BLASTN match, as indicated on the bottom
Detailed information of the blaNDM-5-habouring plasmids reported in the NCBI database
| Inc. group | Transferabilitya | Size (kb) | Host strain | MLST | Sample | Country | Reference |
|---|---|---|---|---|---|---|---|
| IncX3 | T | 46b |
| – | Human Blood | India | [ |
| – | 46b |
| ST1284 | Human Groin | Denmark | [ | |
| – | 46b |
| ST648 | Human Urine | India | [ | |
| C | 46b |
| ST167 | Human Rectum | China | [ | |
| C | 46b |
| ST167 | Human Urine | China | [ | |
| C | 46b |
| ST167 | Human Blood | China | [ | |
| C | 46b |
| ST2608 | Human Swab | China | [ | |
| C | 46b |
| ST5131 | Human Vaginal secretions | China | [ | |
| T | 46b |
| ST167 | Human sputum | China | [ | |
| T | 46b |
| ST167 | Human Urine | China | [ | |
| T | 46b |
| ST167 | Human Blood | China | [ | |
| T | 46b |
| ST167 | Human Blood | China | [ | |
| T | 46b |
| ST206 | Human stool | China | [ | |
| C | 46b |
| – | Human stool | China | [ | |
| C | 46b |
| ST446 | Cows fecal | China | [ | |
| C | 46b |
| ST2 | Cows fecal | China | [ | |
| C | 46b |
| ST3 | Cows fecal | China | [ | |
| C | 46b |
| ST354 | Human ascites | China | this study | |
| C | 46b |
| ST746 | Human feces | China | this study | |
| C | 46b |
| ST6395 | Human blood | China | this study | |
| C | 46b |
| ST6335 | Human pus | China | this study | |
| C | 46b |
| ST12 | Human ascites | China | this study | |
| – | 46b |
| ST410 | Human sputum | China | this study | |
| C | 46b |
| ST361 | Human blood | China | this study | |
| C | 46b |
| ST167 | Human urine | China | this study | |
| – | 46b |
| ST617 | Human Urine | China | this study | |
| C | 46b |
| Human blood | China | this study | ||
| C | 46b |
| – | Human feces | China | this study | |
| IncF | – | > 100 |
| ST648 | Human throat | UK | [ |
| T | > 100 |
| – | Human pus | India | [ | |
| T | > 100 |
| – | Human pus | India | [ | |
| IncFII | T | 84.5 |
| ST34 | Human fecal | China | [ |
| C | 110 |
| ST418 | Human stool | Poland | [ | |
| C | 90 |
| ST418 | Human urine | Spain | [ | |
| IncN | C | 110 |
| ST540 | Human feces | Japan | [ |
| Untypeable | C | 48 |
| ST231 | Human urine | Singapore | [ |
aC: plasmid is able to transfer to E. coli recipients by conjugation; T: plasmid is able to transfer to E. coli recipients by transformation or electroporation
bThese plasmids are identical or near-identical to plasmid pNDM-MGR194